Pentavere is a cutting-edge technology company specializing in AI-driven patient identification and data analytics. Operating in the healthcare sector, Pentavere serves medical professionals, researchers, and healthcare institutions by providing automated data abstraction from Electronic Health Records (EHR). This process is highly accurate and significantly faster than manual methods, enabling large-scale real-world evidence studies. The company's core product is an AI engine that leverages Natural Language Processing (NLP) to extract meaningful, high-quality data from vast amounts of clinical information. This data is then used to identify patients eligible for approved medications or interventions, thereby improving patient outcomes and driving therapy growth. Pentavere's business model revolves around offering its AI and data analytics platform as a service to healthcare providers and research institutions. Revenue is generated through subscription fees and service contracts. The company operates in a niche market focused on rare diseases, oncology, and dermatology, among others. By automating data extraction and analysis, Pentavere helps healthcare professionals make informed decisions more quickly and accurately.

Keywords: AI, patient identification, data analytics, EHR, NLP, healthcare, oncology, rare diseases, automated abstraction, clinical insights.